EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Highly Reproducible Quantification of Serum Neurofilament Light Chain in a Multi‐Center Study

Niels Kruse iD, Jonas Franz iD, Birgit Otte, Leila Husseini iD, Stefan Nessler, Katja Akgün, Nicole Heubner, Falk Steffen, Madeleine Wacker, Steffen Halbgebauer, Matthis Synofzik iD, Hayrettin Tumani iD und 7 weitere

European Journal of Neurology · 2026-11 · 33 (11)

DOI: 10.1111/ene.70803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 18.11.2026. Verfasst von Niels Kruse und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, University Medical Center Göttingen, Göttingen, Germany. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Pharma GmbH, University Medical Center Goettingen-UMG Clinician Scientist Program, DFG Transregional Collaborative Research Center (CRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neurofilament light chain measured in serum (sNfL) is an emerging biomarker for neuro‐axonal injury, but its clinical use requires robust reference values and demonstration of inter‐laboratory comparability.

Methods

This round‐robin study aimed to assess age‐dependent sNfL using the Quanterix HD‐X Analyzer under laboratory conditions that were strictly standardized across all participating sites to exclude technical outliers while providing reference values on an absolute scale. Besides a group of individuals with relapsing–remitting multiple sclerosis (RRMS, n = 24) we measured a cohort of voluntary blood donors ( n = 128) to revisit age‐related cut‐off values under strict laboratory conditions. Measurements were performed in five German laboratories following a standardized protocol, and all reagents and consumables derived from identical kit lots.

Results

In line with previous work, we found that sNfL increased with age by about ~0.15 pg/mL per year within the sampled donor age range of 21–60 years. Also, our results demonstrate that measurements obtained across different laboratories exhibited a high degree of comparability with an average coefficient of variation of 11%. Using quantile regression with identical age‐dependent thresholds across sites, we observed consistent, exploratory separation of the small MS cohort from healthy donors (mean AUC 0.79, 95% CI 0.68–0.88).

Conclusion

Our findings support the analytical robustness as well as inter‐laboratory comparability of sNfL measurements and its use as a serum biomarker in multi‐center studies of neurodegeneration.

Schlagwörter

Stichwörter der Autor:innen

immunoassaymultiple sclerosisneurofilament proteinsreference valuesrelapsing–remittingreproducibility of results

Autor:innen und Institutionen

  • Department of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
  • Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • Fraunhofer Institute for Translational Medicine and Pharmacology, Göttingen, Germany.
  • Department of Neurology, Multiple Sclerosis Center, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, University of Technology Dresden, Dresden, Germany.
  • Department of Neurology, Focus Program Translational Neurosciences (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.

ORCID-Profile: Niels Kruse, Jonas Franz, Leila Husseini, Matthis Synofzik, Hayrettin Tumani, Stefan Bittner, Frauke Zipp, Tjalf Ziemssen, Christine Stadelmann

Förderung

  • Novartis Pharma GmbH
  • University Medical Center Goettingen-UMG Clinician Scientist Program
  • DFG Transregional Collaborative Research Center (CRC)
  • DFG
  • The DFG under Germany's Excellence Strategy
  • The German Center for Child and Adolescent Health (DZKJ)
  • Federal Ministry of Research, Technology and Space (BMFTR)
  • European Union, project European Rare Diseases Research Alliance (ERDERA)

Zitieren

APA

Kruse, N., Franz, J., Otte, B., Husseini, L., Nessler, S., Akgün, K., Heubner, N., Steffen, F., Wacker, M., Halbgebauer, S., Synofzik, M., Tumani, H., Bittner, S., Zipp, F., Ziemssen, T., Riggert, J., Weber, M. S., Brück, W., & Stadelmann, C. (2026). Highly Reproducible Quantification of Serum Neurofilament Light Chain in a Multi‐Center Study. European Journal of Neurology, 33(11). https://doi.org/10.1111/ene.70803

Vancouver

Kruse N, Franz J, Otte B, Husseini L, Nessler S, Akgün K, et al. Highly Reproducible Quantification of Serum Neurofilament Light Chain in a Multi‐Center Study. European Journal of Neurology. 2026;33(11). doi:10.1111/ene.70803

BibTeX
@article{Kruse2026,
  author = {Kruse, Niels and Franz, Jonas and Otte, Birgit and Husseini, Leila and Nessler, Stefan and Akgün, Katja and Heubner, Nicole and Steffen, Falk and Wacker, Madeleine and Halbgebauer, Steffen and Synofzik, Matthis and Tumani, Hayrettin and Bittner, Stefan and Zipp, Frauke and Ziemssen, Tjalf and Riggert, Joachim and Weber, Martin S and Brück, Wolfgang and Stadelmann, Christine},
  title = {Highly Reproducible Quantification of Serum Neurofilament Light Chain in a Multi‐Center Study},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {11},
  doi = {10.1111/ene.70803}
}
Kostenlos starten →